JGC
MTACU

J. Goldman & Co’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

J. Goldman & Co’s Portfolio MTACU Stock Details MTACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-187,020
Closed -$1.88M – 558
2021
Q1 		$1.88M Sell
187,020
-239,677
-56% -$2.55M 0.06% 246
2020
Q4 		$4.48M Buy
+426,697
New +$4.45M 0.23% 118

Other funds holding MTACU

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HP
Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

J. Goldman & Co's MTACU Position: Q2 2021 in Review

J. Goldman & Co sold out of MedTech Acquisition Corporation Unit (MTACU) in Q2 2021, closing a stake of 187,020 shares — an estimated $1.88M sold.

J. Goldman & Co first reported a position in MTACU in Q4 2020 and held it in 2 quarters. The position peaked at $4.48M in Q4 2020. 30 funds tracked by Wall St. Rank hold MTACU as of Q2 2021.

  • J. Goldman & Co reported no remaining MedTech Acquisition Corporation Unit position as of Q2 2021 after selling out during the quarter.
  • J. Goldman & Co sold 187,020 MedTech Acquisition Corporation Unit shares in Q2 2021, an estimated $1.88M.
  • J. Goldman & Co first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 2 quarters.
  • J. Goldman & Co's MedTech Acquisition Corporation Unit position peaked at $4.48M in Q4 2020.
  • 30 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q2 2021.

Based on J. Goldman & Co's 13F filing for Q2 2021, filed 16 Aug 2021.